This inventor holds 1 USPTO granted patent. Top assignee: Wisconsin Alumni Research Foundation. Active years: 2010.
Company Filing History:
Years Active: 2010
Title: Wayne Tam: Innovator in B-cell Lymphoma Diagnosis
Introduction
Wayne Tam is a notable inventor based in Forest Hills, NY (US). He has made significant contributions to the field of medical diagnostics, particularly in the area of B-cell lymphoma. His innovative work has the potential to improve the diagnosis and treatment of this serious condition.
Latest Patents
Wayne Tam holds a patent for the miR-155 assay. This invention provides methods for diagnosing B-cell lymphoma in animals. Specifically, it distinguishes between animals with diffuse large B-cell lymphoma (DLBCL) that have an activated B-cell (ABC) phenotype and those with a non-activated germinal-center (GC) phenotype. The invention also includes methods for identifying compounds that can treat B-cell lymphoma. Additionally, it offers reagents and methods for determining the amount of miR-155 in samples isolated from animals. A set of oligonucleotides is provided for this purpose.
Career Highlights
Wayne Tam is associated with the Wisconsin Alumni Research Foundation, where he continues to advance his research and innovations. His work has garnered attention for its potential impact on veterinary medicine and oncology.
Collaborations
Wayne has collaborated with notable colleagues, including James E. Dahlberg and Peggy S. Eis. Their combined expertise contributes to the advancement of research in the field.
Conclusion
Wayne Tam's contributions to the diagnosis of B-cell lymphoma through his innovative patent demonstrate his commitment to improving animal health. His work exemplifies the importance of research and innovation in the medical field.